First patient dosing represents another major clinical milestone for IHL-42X, building on positive P

Together with the previously announced A$6,039,162.43 refund, Incannex has now received more than A$

First clinical sites approved and actively screening potential participantsRepresents another major

MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasda

Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-m

The granted patent includes claims directed to the proprietary IHL-42X composition and its associate

MELBOURNE, Australia and NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasda

Incannex Healthcare Inc. (NASDAQ:IXHL) ("Incannex" or the "Company"), a clinical-sta

NEW YORK and MELBOURNE, Australia, June 10, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasda

MELBOURNE, Australia and NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasda

Alliance Global Partners analyst James Molloy initiates coverage on Incannex Healthcare (NASDAQ:I

Incannex Healthcare (NASDAQ:IXHL) reported quarterly losses of $(0.35) per share which beat the anal

Major operational milestone achieved as Incannex advances late-stage development of IHL-42X, with al

MELBOURNE, Australia and NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq

Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Techno

Cronos Group (NASDAQ: CRON - Get Free Report) and Incannex Healthcare (NASDAQ: IXHL - Get Free Repor

Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage biopharmaceutical company developing innova

MELBOURNE, Australia and NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasd

Board initiates buyback activity following period of inactivity, with repurchases executed over the

MELBOURNE, Australia and NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasd

Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage biopharmaceutical company developing combin

MELBOURNE, Australia and NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasd

MELBOURNE, Australia and NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasd

U.S. stocks declined, with Dow Jones falling over 500 points while NASDAQ and S&P 500 also dropp

Incannex Healthcare Limited (NASDAQ: IXHL) shares are tumbling on Thursday as the company announced

Incannex shares drop after announcing a $10 million stock offering to fund its IHL-42X sleep apnea s

U.S. stocks down, Dow falls 500+ points. Energy shares up 0.4%, financial stocks down 1.4%. Jobless

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innov

Incannex Healthcare Inc. (NASDAQ:IHXL), ("Incannex" or the "Company") a clinical-sta

NEW YORK and MELBOURNE, Australia, March 12, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasd

Incannex's common stock is expected to begin trading on a post-split adjusted basis on February 27,

Dallas, Texas--(Newsfile Corp. - February 18, 2026) - Incannex Healthcare Inc. (NASDAQ: IXHL): Stone

MELBOURNE, Australia and NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasda

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innov

Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage biopharmaceutical company developing innova

MELBOURNE, Australia and NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (NASDA

MELBOURNE, Australia and NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (NASDA

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for tra